National CineMedia insider plans sale of 13,372 shares via Charles Schwab
Rhea-AI Filing Summary
The Form 144 notifies a proposed sale of 13,372 common shares of National CineMedia, Inc. through The Charles Schwab Corporation on NASDAQ with an aggregate market value of $62,179.80 and an approximate sale date of 08/13/2025. The filing lists the securities were received as restricted stock units on several dates (02/22/2021, 04/01/2021, 07/22/2021, 02/22/2022, 03/26/2024) totaling the units shown. The filing reports no securities sold in the past 3 months. Key details such as the name of the selling individual and the filer’s stated relationship to the issuer are not provided in the form.
Positive
- Securities were acquired as restricted stock units, indicating the shares originated from compensation-related awards.
- No securities sold in the past 3 months is reported, showing no recent dispositions by the selling account within that window.
Negative
- Seller identity and relationship to the issuer are not provided in the filing, limiting interpretability.
- No 10b5-1 plan adoption date or trading-plan details are indicated, so it is unclear whether sales are pre-planned under a trading arrangement.
Insights
TL;DR: Routine Form 144 filing for a proposed insider sale; details suggest limited standalone market impact without more context.
The filing discloses a proposed sale of 13,372 common shares via Charles Schwab with an aggregate market value of $62,179.80 and an approximate sale date of 08/13/2025. All shares reported were acquired as restricted stock units on the dates listed, and the form reports no sales in the past 3 months. The notice lacks the seller's name and a declared relationship to the issuer, which limits interpretation of intent and potential governance signals. On its face this is a standard disclosure rather than a material corporate development.
TL;DR: Disclosure is procedurally correct but incomplete on identity and trading-plan details, constraining governance assessment.
The Form 144 includes required transaction specifics—broker, exchange, number of shares, acquisition dates and nature (restricted stock units)—and a representation about absence of undisclosed material adverse information. However, the filing does not provide the name of the selling individual or the filer’s relationship to the issuer, nor does it indicate a trading-plan adoption date (if any). That absence reduces transparency for stakeholders seeking context on insider liquidity and governance practices.